•  
  •  
 

Abstract

A consequence of the globalization of science and medicine is that more medical research is being conducted in developing countries, often by scientists and clinicians from wealthier countries. This research has the potential to benefit not only the local populations but people around the world. However, conducting health care research in low-income countries also raises important ethical issues. Prioritizing profit, some research entities may wish to take advantage of reduced expenses and less stringent regulations in some countries, and sufficient oversight may be lacking. Should researchers observe the same standard of care in the host countries that they would follow in their own countries, or should they be guided at least in part by local standards? How important is cultural sensitivity in conducting health care research abroad? Socially, economically, and educationally disadvantaged populations are more susceptible to coercion and exploitation, compromising their capacity to provide informed consent. Are placebo controls used more frequently in clinical trials in low-income countries, depriving participants of potentially effective treatments? Even studies conducted in accordance with rigorous medical and ethical standards and focused on diseases most prevalent in developing regions may yield treatments, therapies, and procedures that are beyond the economic reach of many of the people in these regions. What steps should be taken to increase local access to treatments resulting from research? These and other ethical questions are essential in discussions and efforts related to health care research in developing countries.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.